Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide for Obesity in Young Adults with Type 1 Diabetes
NCT06411210Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Jul 2024
- Primary completion
- Apr 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide in obesity, sponsored by Yale University. Started Jul 2024; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06411210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06411210.